Shalby, a company in the Hospital industry, reported revenue of ₹313 crore and net profit of ₹7.89 crore for the September 2026 quarter.
Shalby (NSE: SHALBY) closed at ₹122.15 on 20 Nov 2026, down 45.0% over the past year. Its market capitalisation is ₹1,319 crore and it trades at 33.6 times earnings.
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc. The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.